CRISPR

  • Read more: Consumer Genetics: To Test or Not to Test?

    Consumer Genetics: To Test or Not to Test?

    The Personal Genetics Education Project (pgEd), is committed to working with lawyers and policymakers to bridge the knowledge gap between genetics and law.

  • Read more: Of Risk and Gene Drives

    Of Risk and Gene Drives

    It is possible that particular gene drives will kill us all. But academia’s emphasis on the risks of human, rather than environmental, genetic engineering mean their heads are in the right place.

    Close-up of a mosquito on human skin
  • Read more: Malaria Eradication: For Africa as America

    Malaria Eradication: For Africa as America

    Despite being curable, and eliminated from most developed countries, malaria is the fifth deadliest infectious disease in the world. Gene drives could change that. Let’s give it a try.

    Close up of a mosquito sucking blood on human skin. This mosquito is a carrier of Malaria, Encephalitis, Dengue and Zika virus.
  • Read more: Gene Editing and Intellectual Property: A Useful Mix?

    Gene Editing and Intellectual Property: A Useful Mix?

    Join us March 8 for a talk that will cover the science of genome editing, including CRISPR, and in particular, the scientific advances made in the field since its principal discovery as an engineering tool in 2012.

    Abstract representation of DNA double helix
  • Read more: Can a national conscience be gene edited?

    Can a national conscience be gene edited?

    By Paul McLean Gene editing is at once promising and perilous. Or, as John Oliver said in a recent episode of his news show, it is ”either going to kill all disease or kill every last one of us.” The Nuffield Council on Bioethics is not as amusing as John Oliver, and unlike the summer…

  • Read more: Opportunities and challenges for user-generated licensing models in gene-editing

    Opportunities and challenges for user-generated licensing models in gene-editing

    By Timo Minssen,  Esther van Zimmeren & Jakob Wested  An earlier version of this contribution had been published in Life Science Intellectual Property Review (LSIPR). A voluntary pool or clearinghouse model may give rise to a robust commercial ecosystem for CRISPR and could include special provisions for royalty-free research use by academics. Hence, there may be a path through…